• Human APIs PowderRespiratory Drugs Raw Material Antiviral Antibacterial Antipyretic Analgesics Antihistamine Drugs Antineoplastic Urinary System Drugs Endocrine System Other
  • Pharmaceutical IntermediatesPharmaceutical intermediates Heterocyclic Compound OLED material intermediate Diphenylamine intermediates Nutritional Supplements Pharmaceutical raw materials
  • Medicine ExcipientsFiller Solubilizers Coating material Disintegrant Excipient Iubricant Other
  • Veterinary raw materialsAntibacterial anti-inflammatory Respiratory Drugs Gastrointestinal Drugs Disinfectant Anthelmintics Antiviral drugs Sow health care Feed additives
  • About UsCompany profileQualificationQuality AssuranceService teamFactory TourR&D Center
  • Anti-inflammatory and analgesic Raw Materials powder PARECOXIB SODIUM

    • Anti-inflammatory and analgesic Raw Materials powder PARECOXIB SODIUM
    • Anti-inflammatory and analgesic Raw Materials powder PARECOXIB SODIUM storehouse
    • Anti-inflammatory and analgesic Raw Materials powder PARECOXIB SODIUM quality testing
    • Anti-inflammatory and analgesic Raw Materials powder PARECOXIB SODIUM quality testing
    • Anti-inflammatory and analgesic Raw Materials powder PARECOXIB SODIUM certificate

    Product Overview:

    Ternacin (Parecoxib sodium for injection, trade name Dynastat), the world's first injectable selective cyclooxygenase-2 inhibitor for the short-term treatment of postoperative pain, belongs to the class of non-steroidal anti-inflammatory (NSAID) drugs. Terna is an inactive precursor to vadicxib, which is metabolized by the liver in vivo after injection to function as Vadicxib. In some surgical models, the analgesic effect is comparable to that of injectable opioids, and the analgesic effect can be maintained for 6 to 12 hours or longer. When combined with opioids, opioid dosage and adverse reactions can be reduced.

    Anti-inflammatory and analgesic Raw Materials powder PARECOXIB SODIUM Attributes

    PARECOXIB SODIUM Raw Materials powder

    CAS:198470-85-8

    MF:C17H20Cl2N2S

    PARECOXIB SODIUM

    MW:355.33

    EINECS:200-701-3

    Specification​: 99% min PARECOXIB SODIUM powder

    Sample:PARECOXIB SODIUM powder

    Packaging:1kg/bag, 25kg/drum

    Brand: Henrikang

    Appearance:white

    Storage: Cool Dry Place

    Shelf Life: 2 Years

    Test Method: HPLC

    Anti-inflammatory and analgesic Raw Materials powder PARECOXIB SODIUM Details

    PARECOXIB SODIUM Powder Usage and Synthesis.

    Parecoxib is a precursor of vardecxib. It can selectively inhibit cyclooxygenase-2 (COX-2), inhibit the conversion of arachidonic acid to prostaglandin (PG), and inhibit PG synthesis, thus exerting analgesic and anti-inflammatory effects, while not significantly inhibiting COX-1. Therefore, while exerting analgesic and anti-inflammatory effects, It does not affect gastrointestinal mucosa, platelet and renal function.

    PARECOXIB SODIUM powder

    Use of PARECOXIB SODIUM.

    Parecoxib sodium is helpful for pain, inflammation, and fever, and selectively inhibits the formation of prostaglandins in tissues including endothelial tissue, but has no effect on thromboxanes in platelets. Parecoxib sodium is generally used clinically for the treatment of acute pain after moderate or severe surgery.

    The world's first specific cyclooxygenase-2 (COX-2) inhibitor that can be administered intravenously and intramuscularly for the short-term treatment of post-operative pain, as well as for the treatment of moderate or severe post-operative acute pain.

    PARECOXIB SODIUM

    Pharmacological Effect of PARECOXIB SODIUM.

    Product Method of Bulk PARECOXIB SODIUM Powder.

    Our advantage
    Our Factory
    Shipping
    Tel: 86-29-89601602
    WhatsApp: 8615091775531
    WeChat: 15091775531
    E-mail: sales21@interlgroup.com
    Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
    ©2023 Xi'an Henrikang Biotech Co., Ltd.,